GDUFA Research Outcomes
Post-Approval Monitoring
This section contains scientific publications, presentations, and posters arising from GDUFA-funded research relevant to post-approval monitoring of generic products.
- 
                        Communicating Benefits and Risks of Generic Drugs to Consumers: Patient and Caregiver Opinions of two FDA-Developed Educational Materials
                        Hohmann, Natalie; Garza, Kimberly; Surry, Daniel; Hansen, Richard; Harris, Ilene; Kiptanui, Zippora; Oguntimein, Oluwamurewa; Frost, Mitchell; Qian, Jingjing 
- 
                        Medication Cost-Savings and Utilization of Generic Inhaled Corticosteroid (ICS) and Long-Acting Beta-Agonist (LABA) Drug Products in the USA
                        Wang, Zhong; Ahluwalia, Sharon; Newman, Bryan; Dhapare, Sneha; Zhao, Liang; Luke, Markham 
- 
                        Correction to: Outcomes Associated with Generic Drugs Approved Using Product-Specific Determinations of Therapeutic Equivalence
                        Gagne, Joshua; Polinski, Jennifer; Jiang, Wenlei; Dutcher, Sarah; Xie, Jing; Lii, Joyce; Fulchino, Lisa; Kesselheim, Aaron 
- 
                        Random-Effects Linear Modeling and Sample Size Tables for Two Special Cross-over Designs of Average Bioequivalence Studies: the 4-Period, 2-Sequence, 2 Formulation and 6-Period, 3-Sequence, 3-Formulation Designs
                        Diaz, Francisco; Berg, Michael; Krebill, Ron; Welty, Timothy; Gidal, Barry; Alloway, Rita; Privitera, Michael 
- 
                        Predicting Tacrolimus Concentrations in Children Receiving a Heart Transplant Using a Population Pharmacokinetic Model
                        Rower, Joseph; Stockmann, Chris; Linakis, Matthew; Kumar, Shaun; Liu, Xiaoxi; Korgenski, Kent; Sherwin, Catherine 
- 
                        Association between Higher Generic Drug Use and Medicare Part D Star Ratings: An Observational Analysis
                        Hohmann, Natalie; Hansen, Richard; Garza, Kimberly; Harris, Ilene; Kiptanui, Zippora; Qian, Jingjing 
- 
                        Model-Based Assessment Using Conventional Bioequivalence Limits to Ensure Safety and Efficacy of Rivaroxaban in Patients Undergoing Hip or Knee Replacement
                        Gonzalez-Sales, Mario; Fang, Lanyan; Kim, Myong Jin; Zhao, Liang 
- 
                        Erratum to: Generic Development of Topical Dermatologic Products: Formulation Development, Process Development, and Testing of Topical Dermatologic Products
                        Chang, Rong-Kun; Raw, Andre; Lionberger, Robert; Yu, Lawrence 
- 
                        Variations in Patients’ Perceptions and Use of Generic Drugs: Results of a National Survey
                        Kesselheim, Aaron; Gagne, Joshua; Franklin, Jessica; Eddings, Wesley; Fulchino, Lisa; Avorn, Jerry; Campbell, Eric 
- 
                        Physiologically Based Pharmacokinetics Modeling to Investigate Formulation Factors Influencing the Generic Substitution of Dabigatran Etexilate
                        Farhan, Nashid; Cristofoletti, Rodrigo; Basu, Sumit; Kim, Sarah; Lingineni, Karthik; Jiang, Sibo; Brown, Joshua; Fang, Lanyan; Lesko, Lawrence; Schmidt, Stephan